LAMB-Dx Allergy Diagnostic

About Immunovent

Immunovent is a private, pre-revenue diagnostics company developing a novel, needle-free allergy testing platform called LAMB-Dx. The technology involves a gentle mucosal brush sample from symptomatic areas, coupled with a proprietary assay, to provide more accurate local allergy diagnoses, particularly for patients misdiagnosed by conventional methods. The company has completed proof-of-concept studies, is optimizing protocols, and anticipates launching its first diagnostic product, targeting a significant portion of the $1.2 billion annual allergy testing market where current methods fail up to 20% of symptomatic patients.

Therapeutic Areas